Journal of Diabetes Research / 2016 / Article / Tab 1

Clinical Study

Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial

Table 1

Baseline characteristics of the patients.

CGM pre-CSIICGM post-CSIITotal

Sex (female/male) (number)6/55/611/11
Age (years) (mean, range)38.5, 20–5934.8, 19–4536.6, 19–59
Body-mass index (Kg/m2) (mean ± SD)
Diabetes duration (years) (mean ± SD)
Daily insulin doses (units/Kg/day) (mean ± SD)

RT-CGM pre-CSII: real-time continuous glucose monitoring before continuous subcutaneous insulin infusion; RT-CGM post-CSII: real-time continuous glucose monitoring after continuous subcutaneous insulin infusion.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.